Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2023, on Tuesday, March 19, 2024, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Wednesday, March 20, 2024, to discuss the results and provide a business update.

Conference Call Details:

 

Date:

Wednesday, March 20, 2024

Time:

8:00 a.m. Eastern time

Participant Dial-in:

1-833-953-2434 (U.S.)
1-412-317-5763 (International)

Replay Dial-in (Passcode 6766979):

(telephonic replay through March 27, 2024)

1-877-344-7529 (U.S.)
1-412-317-0088 (International)

Webcast: (online replay through March 20, 2025)

harrow.com

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240305397352/en/

The Harrow Health Stock at the time of publication of the news with a raise of +2,37 % to 11,21USD on Nasdaq stock exchange (05. März 2024, 02:00 Uhr).